PDF herunterladen
Open Access
CC BY-NC-ND 4.0 · Journal of Gastrointestinal Infections 2025; 15(01/02): 22-25
DOI: 10.1055/s-0045-1811266
Brief Report

Secondary Analysis for Surveillance of Hepatitis C Virus Transmission from a Secondary-Level Hospital in Himachal Pradesh, India: A Brief Report

Autor*innen

  • Vandana Sharma 

    1   RT-PCR Laboratory at Palkwah, Regional Hospital Una, Una, Himachal Pradesh, India

  • Mahima Mahima

    1   RT-PCR Laboratory at Palkwah, Regional Hospital Una, Una, Himachal Pradesh, India

  • Rahul Kaundal

    2   Regional Hospital Una, Una, Himachal Pradesh, India

  • Sanjay Mankotia

    2   Regional Hospital Una, Una, Himachal Pradesh, India

  • Dinesh Kumar

    3   Department of Community Medicine, Dr. Rajendra Prasad Government Medical College Kangra at Tanda, Himachal Pradesh, India

Funding Not applicable.
Weitere Informationen
Auch verfügbar auf
  Lizenzen und Reprints

Abstract

The National Viral Hepatitis Control Program (NVHCP) in India provides free diagnostic and therapeutic services. Analysis of secondary data under the program helps to understand about hepatitis and its associated risk factors. The present study was undertaken to analyze the secondary data (April 2023–December 2024) for hepatitis C virus (HCV) infection and associated factors at a secondary hospital in Himachal Pradesh, India. A total of 283 records were evaluated, where majority of the patients (69.6%) belonged to rural area. About half (52.0%) HCV-positive patients with mean hepatitis C viral load of 0.95 × 105 IU/mL were people who inject drugs (PWIDs). Additionally, PWIDs showed a high HCV positivity rate (63.1%). Odds of HCV infection was found to be significantly higher in males (odds ratio [OR]; 2.4; 95% CI: 1.2–4.7) and PWIDs (1.8; 95% CI: 1.1–3.0). Hepatitis C viral load among HCV-positive patients was not associated with gender, area (rural/urban), and PWID status. Occurrence of co-infection with human immunodeficiency virus (HIV) in HCV-positive PWIDs is also observed. Hence, there is a need to share information between NVHCP and National HIV/acquired immune deficiency syndrome Control Program for surveillance and formulation of public health interventions toward achieving elimination targets set by World Health Organization for 2030.

Keywords

hepatitis C virus - injection use - hepatitis C viral load

Ethical Approvals and Consent

This study is the outcome of retrospectively analyzed data maintained in our district hospital. Therefore, ethical approval and consent were not required.


Author Contributions

V.S. conceptualized the study, analyzed the data, and wrote the manuscript. M.M. helped in data collection and compilation. R.K. and S.M. critically revised the manuscript and provided administrative support. D.K. helped in data analysis, interpretation, and manuscript writing. All the authors read and approved the final version of manuscript.




Publikationsverlauf

Eingereicht: 13. Mai 2025

Angenommen: 28. Juli 2025

Artikel online veröffentlicht:
06. Oktober 2025

© 2025. Gastrointestinal Infection Society of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India